A Surviving Beta Cell Subpopulation Enriched in Patients with Type 1 Diabetes - Max Spurrell

Biosensor Cell Array Reveals Temporal GABA Secretion Dynamics from Pancreatic Islets-Austin Stis PhD

Soluble LAG-3 Identifies an Early T cell Activation Window in self-reactivity Type 1 Diabetes

Genetic Association and Machine Learning Improve the Prediction of Type 1 Diabetes Risk

Reprogramming Innate & Adaptive Immunity for Durable Islet Allograft Survival - Haval Shirwan, PhD

ATG: Clinical History, Mechanistic Insights, & Future Directions for Type 1 Diabetes Treatment

Bioelectronic devices for immune protection and oxygenation of islets in vivo - Siddharth Krishnan

From Oxygen Limitation to Opportunity: Defining Hypoxia Resistance in Pancreatic Islets

Iron Deficiency Induces Maturation-dependent Loss of Beta Cells - Annelore Van Mulders

A Combinatorial Transcription Factor Screening Platform for Immune Cell Reprogramming-Filipe Pereira

Beta Cells Fight Back: Metabolic Reprogramming Shapes Immune Tolerance in Type 1 Diabetes-Kevin Bode

New Clinical Trials of Disease-modifying Therapy Should Focus on New-Onset & not Preclinical T1D

Quantitative V-gene-targeted T cell Receptor Sequencing as a Biomarker in Type 1 Diabetes

NKX6.1: Actionable Biomarker linked to Islet Function & Islet Transplantation Clinical Outcomes

Advancing Suspension Manufacturing of Islets In Vertical Wheel Bioreactors for Diabetes Therapy

Investigating Therapeutic Delivery to Beta-cells with Lipid Nanoparticles - Jacob Enriquez, PhD

Eledon T1D Trial: Immunomodulation with a CD40L antibody in combo with Transplanted Islet Cells

Long Non-coding RNAs (lncRNA) as a Novel Source of Beta Cell Autoantigens in Type 1 Diabetes

Can Islets Evade the Immune System Safely: Designing Tolerance without Compromising Host Defense

Linking Biological Rhythms to Beta Cell Maturation - Juan Alvarez, PhD, UPenn

Glucagon Secretion by Panc Alpha-cells Requires an Intact Tubulin-Cytoskeleton-Primary Cilium Axis

Saliva-based at-home GRS Testing for Scalable & Accessible T1D Screening - Yuta Matsuda, T1D Scout

Human Pancreas Integrated histopath through T1D progression - Verena van der Heide & Sara McArdle

the(sugar)science presents: the Diabdocs 2025 Cohort

High-throughput perturbation screens to decode human immune states-a sc cytokine dictionary of blood

Longitudinal monitoring of Type 1 Diabetes progression to disease onset - Lonnie Shea, PhD

Type 1 Diabetes Monitoring Panel - Challenges for Implementation and Engagement

Type 1 Diabetes Screening Panel: Moving from Research to Clinical Implementation

Panel: What would the earliest detection of Type 1 Diabetes look like?

Goal-oriented in Silicon Perturbations: Novel Counterfactual Deep Learning Framework in T1D

How the Human Immunome Project/IHM may inform Type 1 Diabetes - John Tsang, PhD, Yale

WAVE T1D Clinical Trial: Multicenter RCT Combo therapy in New-Onset Type 1 Diabetes

Multiscale Microenvironment Control in Stem Cell-Derived Pancreatic Progenitor Production

IL-17 Deficiency Protects NOD Mice from Diabetes through Altering Intestinal Antigen Presentation

Islet Cellularity in Health & Type 1 Diabetes: insights from deep tissue 3D imaging-Ulf Ahlgren, PhD

2025 Most Watched Highlights: Fast Tracking Stem Cell Derived Islets to the Clinic - What is Needed?

2025 Most Watched Highlights: Peter Thompson, PhD, & Jasmine Pipella, PhD Candidate

2025 Most Watched Highlights: Xin Chen, PhD

2025 Most Watched Highlights:Thomas Hill, PhD

2025 Most Watched Highlights: Ulf Hannelius, CEO

2025 Most Watched Highlights: Luc Teyton, MD PhD

2025 Most Watched Highlights: Sonja Schrepfer, MD PhD, & Curtis Cetrulo, MD

2025 Most Watched Highlights: Rene van Tienhoven, PhD

2025 Most Watched Highlight: Eric Chang, PhD

2025 Most Watched Highlights: Sana Biotech Update

State of the Science: Fast Tracking Stem cell derived islets to the clinic-what is needed?

Small Things Matter: Lack of Extra Islet Beta Cells in T1D - Katy Murall, PhD, University of Exeter

T1D Th1nk Tank: Christof Westenfelder, MD CEO, SymbioCellTech

Code to Cure: Build Models, Agents, AI-XR, co-scientists to Drive Biomedical Innovation

The Search for Diabetes-Specific T-cell Repertoires - Michel Edwar Mickael, PhD

Serum Metabolic Profiling Reveals Gut Microbiota-linked Differences in T1D in Discordant Twins

Improving Prediction of Type 1 Diabetes Across Studies - Erin Templeman, PhD Candidate Oram Lab

Transcriptomics of Autoimmune Disease Identifies FGFR1 as a Target for Panc Beta-Cell Protection

Molecular Mechanisms of Human Pancreatic Islet Dysfunction Under Overnutrition Metabolic Stress

Transcriptomic & Functional Divergence of Stem Cell-derived & Primary Islets Under Acute Hypoxia

1c Metabolisms in CD8 T cell Responses during Type 1 Diabetes - Gabriela Ramirez-Hernandez, PhD

Endogenous Retroviruses & Type 1 Diabetes Conserved & Mutated Epitopes of the Virus-like Gag Antigen

Immune & Apoptosis-Related Gene Signatures in Alpha & Beta Cells Contribute to their Fate in T1D

Hematopoietic Stem Cell Transplantation Promotes Islet Transplant Tolerance & Diabetes Reversal

D Challenge 2025 Bootcamp: PANC-DB and PanKbase